Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Ramipro;Tritace;Prilace;Altace

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicine Supply Notification: Ramipril 1.25mg capsules
    Medicine Supply Notification: Ramipril 1.25mg capsules

    23 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7205620

    FIRSTWORD PHARMA
    23 Apr 2026
    Share Share
    Enforcement Report - Week of November 27, 2024
    Enforcement Report - Week of November 27, 2024

    27 Nov 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-27-2024-27890.pdf

    FDA
    27 Nov 2024
    Share Share
    Health Canada Issues Recall of Laboratoire Riva's Ramipril 5 mg
    Health Canada Issues Recall of Laboratoire Riva's Ramipril 5 mg

    12 Nov 2020

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-laboratoire-rivas-ramipril-5-mg-1605673664.pdf

    HEALTH CANADA
    12 Nov 2020
    Share Share
    UC San Diego to assess hypertension drug Ramipril for Covid-19
    UC San Diego to assess hypertension drug Ramipril for Covid-19

    04 May 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/uc-san-diego-ramipril-covid-19/

    CLINICALTRIALSARENA
    04 May 2020
    Share Share
    UC San Diego to assess hypertension drug Ramipril for Covid-19
    UC San Diego to assess hypertension drug Ramipril for Covid-19

    01 May 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/uc-san-diego-ramipril-covid-19/

    CLINICALTRIALSARENA
    01 May 2020
    Share Share
    Health Canada Issues Recall of Teva Canada Ramipril
    Health Canada Issues Recall of Teva Canada Ramipril

    01 Feb 2020

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-teva-canada-ramipril-1580879537.pdf

    HEALTH CANADA
    01 Feb 2020
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.